Table 1.
Liver Transplantation and Liver Resection compared.
| Liver Resection | Liver Transplantation | p | |
|---|---|---|---|
| N = 28 | N = 10 | ||
| Sex [f] | 10 (35.7%) | 7 (70.0%) | 0.078 |
| Age [years] | 1.00 [0.00;2.00] | 2.00 [2.00;3.00] | 0.069 |
| Age Groups [years] | 0.328 | ||
| <1 | 9 (32.1%) | 1 (10.0%) | |
| 1–2 | 13 (46.4%) | 5 (50.0%) | |
| ≥3 | 6 (21.4%) | 4 (40.0%) | |
| PreTEXT | 0.002 | ||
| 1 | 7 (25.9%) | 0 (0.00%) | |
| 2 | 10 (37.0%) | 0 (0.00%) | |
| 3 | 9 (33.3%) | 5 (55.6%) | |
| 4 | 1 (3.70%) | 4 (44.4%) | |
| Metastasis | 8 (28.6%) | 3 (30.0%) | 1.000 |
| Metastasis Localization | 0.101 | ||
| bone and spinal | 1 (3.57%) | 0 (0.00%) | |
| lung | 7 (25.0%) | 1 (10.0%) | |
| Operative Time [min] | 168 (50.5) | 392 (103) | <0.001 |
| Hospital Stay [d] | 15.5 [10.0;21.2] | 34.0 [28.0;44.0] | 0.001 |
| Intensive Care Unit [d] | 3.50 [2.00;6.00] | 23.0 [19.0;29.0] | <0.001 |
| Complications | 16 (57.1%) | 6 (60.0%) | 1.000 |
| Clavien–Dindo | 0.087 | ||
| 0 | 12 (42.9%) | 4 (40.0%) | |
| 1 | 2 (7.14%) | 0 (0.00%) | |
| 2 | 8 (28.6%) | 1 (10.0%) | |
| 3a | 1 (3.57%) | 0 (0.00%) | |
| 3b | 2 (7.14%) | 5 (50.0%) | |
| 4a | 3 (10.7%) | 0 (0.00%) | |
| Follow-up in years | 5.00 [3.00;7.00] | 14.0 [4.25;18.5] | 0.093 |
| Neoadjuvant Chemotherapy | 27 (96.4%) | 9 (90%) | 0.43 |
| Adjuvant Chemotherapy | 27 (96.4%) | 1 (12.5%) | <0.001 |
| AFP | 0.178 | ||
| <999 | 0 (0.00%) | 1 (12.5%) | |
| 1000–9999 | 5 (20.8%) | 0 (0.00%) | |
| 10,000–99,999 | 6 (25.0%) | 4 (50.0%) | |
| 100,000–999,999 | 11 (45.8%) | 3 (37.5%) | |
| >1,000,000 | 2 (8.33%) | 0 (0.00%) |
AFP: alpha-fetoprotein.